Pharmaceutics International, Inc. reported this breach to the New Hampshire Attorney General. Affected individuals who received a notification letter may be entitled to financial compensation through a class action lawsuit — at no cost to you.
According to the New Hampshire Attorney General filing, the following types of personal information were compromised in the Pharmaceutics International, Inc. data breach:
Each type of exposed data strengthens your legal claim. Courts have consistently recognized that the unauthorized disclosure of this information constitutes actionable harm.
Pharmaceutics International, Inc. operates as a specialized contract development and manufacturing organization (CDMO) within the highly regulated life sciences and pharmaceutical sector. The company provides formulation development, analytical testing, clinical trial manufacturing, and commercial production services for major pharmaceutical and biotechnology firms. Because of its core operations, Pharmaceutics International occupies a vital yet sensitive position in the healthcare and pharmaceutical supply chain, maintaining extensive networks and data repositories that intersect with both commercial drug development and healthcare delivery.
In 2025, Pharmaceutics International, Inc. reported a significant cybersecurity incident to the New Hampshire Attorney General, triggering mandatory breach notifications to impacted individuals. Within the pharmaceutical and life sciences sector, security incidents of this magnitude typically involve sophisticated cyberattacks, such as ransomware deployments, unauthorized intrusion into proprietary database networks, or compromises within third-party vendor ecosystems. Given the intellectual property and sensitive administrative data inherent to pharmaceutical manufacturing, threat actors increasingly target these environments to exfiltrate proprietary research, corporate records, and internal personnel files.
The data compromised in incidents involving organizations like Pharmaceutics International routinely includes sensitive personally identifiable information (PII) belonging to employees, clinical trial participants, and business partners. Exposed categories frequently encompass full names, dates of birth, Social Security numbers, banking and payroll details, and potentially specialized health-related records. The exposure of this information creates severe, long-term risks for victims. Social Security numbers and dates of birth serve as the foundational keys for identity theft, tax fraud, and unauthorized credit applications, while financial and direct deposit details leave victims immediately vulnerable to account takeover and unauthorized fund transfers.
As an entity handling sensitive personal and employment data, Pharmaceutics International, Inc. was bound by stringent legal obligations under state data protection statutes, common law duties of care, and applicable federal regulations such as the Federal Trade Commission Act. These legal frameworks mandate the implementation of robust administrative, technical, and physical safeguards—including multi-factor authentication, network segmentation, regular vulnerability testing, and prompt patching of known system flaws. The occurrence of a data breach capable of exfiltrating sensitive PII strongly suggests systemic failures in maintaining these mandatory security protocols, raising serious questions regarding negligence and inadequate data protection.
Receiving a formal data breach notification letter from Pharmaceutics International, Inc. represents more than just a routine administrative notice; it serves as a formal legal admission that the company failed to safeguard your confidential personal information. Under modern legal standards, the receipt of this notice establishes the concrete injury and legal standing required to participate in a class action lawsuit aimed at holding the company accountable. Affected individuals do not need to demonstrate actual financial loss or identity theft to seek legal redress. Our firm evaluates and investigates these data breach matters on a strict contingency fee basis, meaning you pay nothing out of pocket and owe no legal fees unless we successfully recover compensation on your behalf.
You do not need to prove you were financially harmed to qualify. Courts have recognized that the exposure of personal data itself constitutes actionable harm. You may qualify if any of the following apply:
You received a data breach notification letter from Pharmaceutics International, Inc.
You were a customer, patient, employee, or client of Pharmaceutics International, Inc.
Your personal information was stored in Pharmaceutics International, Inc.'s systems
Your Social Security number or driver's license number was exposed
Your financial account, credit card, or banking information was disclosed
You reside in the United States (all 50 states eligible)
That letter is legally required and confirms your data was exposed. It also gives you standing to file a claim.
What your notification letter means & what to do next →Take these steps immediately to protect yourself and preserve your right to compensation.
Your Pharmaceutics International, Inc. data breach notification letter is legal evidence. Store it in a safe place — physical and digital copies. It establishes that you were affected by this breach and strengthens your claim for compensation.
Pharmaceutics International, Inc. is typically required to offer free credit monitoring to affected individuals. Check your notification letter for enrollment instructions and use all offered services — they help detect fraud early and document harm.
Contact Equifax, Experian, and TransUnion to place a free credit freeze. This prevents new accounts from being opened in your name and protects you from identity theft. You can lift the freeze at any time.
You have a limited window to file a claim. Contact our attorneys today for a free, no-obligation case review. We handle all Pharmaceutics International, Inc. data breach cases on a contingency basis — you pay nothing unless we win.
Security Incident
Prior to AG notification
Unauthorized access to Pharmaceutics International, Inc.'s systems containing personal information.
Reported to Attorney General
December 22, 2025
Pharmaceutics International, Inc. filed an official data breach notice with the New Hampshire AG.
Consumer Notification Letters Sent
Within weeks of AG filing
State law requires companies to mail notification letters to all affected individuals.
Legal Window — Act Now
Statute of limitations applies
State law sets a deadline to file claims. Waiting can forfeit your right to compensation.
Data breach victims may be entitled to several forms of compensation. The specific amounts depend on your state, the type of data exposed, and the company's conduct.
States like California allow $100–$750 per incident regardless of actual harm. Other states provide separate statutory remedies for data breach victims.
Reimbursement for any fraud charges, unauthorized transactions, or expenses you incurred as a direct result of the breach.
Compensation for hours spent monitoring accounts, disputing fraud, freezing credit, and dealing with the aftermath of the breach.
Reimbursement for the cost of credit monitoring services, identity theft protection, and related identity restoration expenses.
SSN and driver's license exposure creates long-term identity theft risk. Courts recognize the ongoing value of this harm and may award damages accordingly.
Exposure of financial account or credit/debit card information entitles victims to recover for actual and potential fraud losses.
New Hampshire's breach notification law (RSA 359-C) requires timely notice to affected individuals and the Attorney General. New Hampshire residents may pursue civil action for actual damages and attorney's fees stemming from inadequate data protection.
These companies also reported data breaches to the New Hampshire Attorney General. If you received a letter from any of these organizations, you may also be entitled to compensation.
One Medical
New Hampshire · Jul 2026
Town of Canterbury, NH
New Hampshire · Jun 2026
Center for Advanced Eye
New Hampshire · Jun 2026
West Series of Lockton Companies, LLC
New Hampshire · Jun 2026
Easterly Government Properties, Inc.
New Hampshire · Jun 2026
Open Arms Care Corporation
New Hampshire · Jun 2026
Contact us for a FREE consultation. No fee unless we win your case.
(786) 306-7278Free Claim ReviewLaw Office of David S. Harris